A phase I clinical trial with OncoVEXGM-CSF

被引：0
|
作者：
Hu, J
McNeish, I
Shorrock, C
Steiner, J
Love, C
Coffin, R
Coombes, C
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] BioVex Ltd, Abingdon, Oxon, England
[3] Oxford Therapeut Consulting, Oxford, England
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1160
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [41] Safety and tolerability of phenserine confirmed in phase I clinical trial
    不详
    DRUG NEWS & PERSPECTIVES, 2000, 13 (02) : 115 - 115
  • [42] Phase I clinical trial of percutaneous cryoablation for osteoid osteoma
    Miyazaki, Masaya
    Saito, Kenichi
    Yanagawa, Takashi
    Chikuda, Hirotaka
    Tsushima, Yoshito
    JAPANESE JOURNAL OF RADIOLOGY, 2018, 36 (11) : 669 - 675
  • [43] Nasal influenza vaccine enters Phase I clinical trial
    不详
    EXPERT REVIEW OF VACCINES, 2007, 6 (03) : 305 - 305
  • [44] Adaptive clinical trial designs for phase I cancer studies
    Sverdlov, Oleksandr
    Wong, Weng Kee
    Ryeznik, Yevgen
    STATISTICS SURVEYS, 2014, 8 : 2 - 44
  • [45] An application of a factorial design to a phase I clinical trial.
    Carr, A
    Montague, TH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P64 - P64
  • [46] Patient specific dosing in a cancer phase I clinical trial
    Babb, JS
    Rogatko, A
    STATISTICS IN MEDICINE, 2001, 20 (14) : 2079 - 2090
  • [47] THE CDRH HELIX - A PHASE-I CLINICAL-TRIAL
    SHIMM, DS
    CETAS, TC
    HYNYNEN, KH
    BUECHLER, DN
    ANHALT, DP
    SYKES, HF
    CASSADY, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (02): : 110 - 113
  • [48] Phase I and II clinical trial design for targeted agents
    Richard L. Schilsky
    Targeted Oncology, 2006, 1 : 220 - 227
  • [49] Phase I and II clinical trial design for targeted agents
    Schilsky, Richard L.
    TARGETED ONCOLOGY, 2006, 1 (04) : 220 - 227
  • [50] Phase I clinical trial design in cancer drug development
    Eisenhauer, EA
    O'Dwyer, PJ
    Christian, M
    Humphrey, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 684 - 692
12345